Bristol-Myers Squibb Company
Bristol-Myers Squibb Company (NYSE: BMY) is trading at $62.20, about ₹5,972 at today's USD/INR rate, as of 25 Sep 2026, 1:32 PM ET, up 1.15% today. Indian residents can buy Bristol-Myers Squibb from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
$61.39
Today's high
$62.28
52 week low
$42.52
52 week high
$68.64
BMY opened at $61.75, closed previously at $61.50, and has traded between $42.52 and $68.64 over the past 52 weeks.
About
Bristol-Myers Squibb Company operates as a global biopharmaceutical entity, actively involved in the research, development, licensing, production, and worldwide commercialization of its medicinal portfolio. The company's therapeutic areas span hematology, oncology, cardiovascular health, immunology, fibrotic conditions, neuroscience, and infectious diseases like COVID-19. Its significant pharmaceutical offerings include Revlimid, an oral immunomodulatory agent for multiple myeloma, and Eliquis, an oral anticoagulant crucial for reducing stroke risk and systemic embolism in non-valvular atrial fibrillation, as well as treating deep vein thrombosis and pulmonary embolism. The portfolio also features Opdivo, utilized across various anti-cancer indications; Pomalyst/Imnovid, prescribed for multiple myeloma patients; and Orencia, targeting active rheumatoid arthritis and psoriatic arthritis in adults. Other key therapies are Sprycel, employed in the management of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy, indicated for patients with unresectable or metastatic melanoma; and Abraxane, a protein-bound chemotherapy formulation. Furthermore, Bristol-Myers Squibb offers Reblozyl, addressing anemia in adult patients with beta thalassemia; Empliciti, another treatment option for multiple myeloma; and Zeposia, designed to treat relapsing forms of multiple sclerosis. Revolutionary treatments like Breyanzi, a CD19-directed genetically modified autologous T cell immunotherapy for adult patients battling relapsed or refractory large B-cell lymphoma, are also part of its lineup. Completing its product range are Inrebic, an oral kinase inhibitor specifically for adult myelofibrosis, and Onureg, used in the treatment of adult patients with acute myeloid leukemia (AML). Bristol-Myers Squibb distributes its pharmaceutical products through a diverse network encompassing wholesalers, distributors, pharmacies, retail outlets, hospitals, clinics, and governmental organizations. Founded in 1887 and formerly known as Bristol-Myers Company, the firm maintains its headquarters in New York, New York.
Key statistics
Avg. volume
11.59M
Market cap
$127.06B
P/E Ratio
13.70
Price-to-sales ratio
2.58
Enterprise value
$161.45B
Free cash flow yield
9.00%
Debt-to-equity ratio
1.93
Return on equity
46.75%
ROIC
15.47%
Beta
0.23
Dividend yield
4.04%
Last dividend
$2.51
Financial overview
Revenue
$48.20B
Earnings per share
$3.46
Free cash flow
$12.85B
Net profit margin
18.87%
Gross margin
70.16%
EBITDA
$15.23B
Revenue growth
-0.22%
Similar securities
This is not an investment recommendation
How to buy Bristol-Myers Squibb from India
Indian residents can buy Bristol-Myers Squibb shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.
Search for Bristol-Myers Squibb and place an order
Find Bristol-Myers Squibb by name or by its ticker, BMY, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Bristol-Myers Squibb trades 7:00 pm – 1:30 am IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Bristol-Myers Squibb position in USD and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.
Read the full guide: how to invest in Bristol-Myers Squibb from India
Trading and taxes when buying Bristol-Myers Squibb from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm ET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. The US withholds tax on dividends paid to Indian residents at the treaty rate; Paasa files Form W-8BEN for you, and the tax withheld can generally be claimed as a credit in India. Bristol-Myers Squibb’s current yield is 4.04%.Dividend tax explained
- US estate tax
- May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator
Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
FAQs
Can Indian residents buy Bristol-Myers Squibb stock?
Yes. Bristol-Myers Squibb (BMY) has been listed on the New York Stock Exchange since 1972, in the Drug Manufacturers - General industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
How much does one Bristol-Myers Squibb share cost in rupees?
One Bristol-Myers Squibb share is $62.20 — about ₹5,972 at a USD/INR rate of 96.02 on 24 Sep 2026. Both the Bristol-Myers Squibb price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Bristol-Myers Squibb from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
Can I buy whole shares of Bristol-Myers Squibb?
Yes. One Bristol-Myers Squibb share is $62.20, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in Bristol-Myers Squibb.
How are gains on Bristol-Myers Squibb shares taxed in India?
The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Bristol-Myers Squibb price. Paasa issues a capital-gains statement for your return.
Does Bristol-Myers Squibb pay a dividend, and how is it taxed in India?
Yes. Bristol-Myers Squibb pays a dividend and the current yield is 4.04%; the last declared dividend was $2.51 per share, about ₹241.01. Dividends are taxed at your slab rate in India. The US withholds tax on dividends paid to Indian residents at the treaty rate; Paasa files Form W-8BEN for you, and the tax withheld can generally be claimed as a credit in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.
When can I trade Bristol-Myers Squibb from India?
The New York Stock Exchange trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.
Is there estate or inheritance tax on Bristol-Myers Squibb shares held from India?
US-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons. It applies to your overall holdings in that jurisdiction rather than to any one position. Paasa's US estate tax calculator shows the exposure for a given portfolio value.
Do I have to declare Bristol-Myers Squibb shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Bristol-Myers Squibb holding, its cost and its closing value.
How do I sell Bristol-Myers Squibb and bring the money back to India?
You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.